Position in AZN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,725,007
+$299,683 QoQ
Shares Held
30,192
+9.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
#377
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 90%
Shared 2%
None 8%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ramirez Asset Management, Inc. holds $30,805,111 across 7 Drug Manufacturers - General names. AZN ranks #3 (18.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,509 | $18,601,961 | |
| 2 | ABBV |
AbbVie Inc.
|
23,922 | $6,019,732 | |
| 3 | AZN |
Astrazeneca PLC
This page
|
30,192 | $5,725,007 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
5,016 | $289,021 | |
| 5 | JNJ |
Johnson & Johnson
|
626 | $158,985 | |
| 6 | PFE |
Pfizer Inc
|
336 | $8,090 | |
| 7 | GRFS |
Grifols SA
|
327 | $2,315 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,725,007 | 30,192 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $5,425,324 | 27,509 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||